Advanced Age-Related Macular Degeneration
Geographic Atrophy Secondary to AMD: Optimizing Patient Selection for Novel Therapeutics
This activity is supported by educational grants from Astellas and Topcon Healthcare, Inc.
SimulatED: Pioneering Treat and Extend Therapy – The Impact of Early Application
This activity is supported by an educational grant from MJH Associates, Inc.; Regeneron Healthcare Solutions, Inc.
Geographic Atrophy Secondary to Age-Related Macular Degeneration: Innovative Therapies for Sight Revival
This activity is supported by educational grants from Apellis Pharmaceuticals, Inc., and Topcon Healthcare, Inc.
nAMD and DME Management: Scaling Real-World Heights in Durability
This activity is supported by an educational grant from Genentech, a member of the Roche Group.
VIDEO: AMD research should focus on regenerative medicine to restore vision
In a video interview, Majda Hadziahmetovic, MD, retinal specialist and assistant professor of ophthalmology at Duke University discusses improving early detection and risk prediction for AMD patients.
Pravin U. Dugel, MD, becomes president, CEO of Ocular Therapeutix
Ocular Therapeutix announced changes to its executive team, with Pravin U. Dugel, MD, assuming the roles of president and CEO and Antony Mattessich stepping down from these positions, effective immediately.
VIDEO: Clinicians now can provide 'some level of hope' in geographic atrophy
Healio spoke with Yasha Modi, MD, to discuss the importance of increasing awareness of geographic atrophy.
VIDEO: Archway port delivery system ‘exciting’ for patients, physicians
In this video, Arshad M. Khanani, MD, MA, clinical associate professor of ophthalmology, University of Nevada, discussed the ARCHWAY study presented at the virtual American Academy of Ophthalmology annual meeting.